Journal of Jilin University(Medicine Edition) ›› 2024, Vol. 50 ›› Issue (1): 161-167.doi: 10.13481/j.1671-587X.20240120
• Research in clinical medicine • Previous Articles Next Articles
Yang YU,Dan TIAN,Donghe NI,Duo ZHANG(
)
Received:2023-01-31
Online:2024-01-28
Published:2024-01-31
Contact:
Duo ZHANG
E-mail:beihuazhangduo@126.com
CLC Number:
Yang YU,Dan TIAN,Donghe NI,Duo ZHANG. Network pharmacologry and molecular docking analysis based on mechanism of monk fruit in treatment of diabetic nephropathy[J].Journal of Jilin University(Medicine Edition), 2024, 50(1): 161-167.
Tab.2
PPI network targets and topological parameters"
| Name | Degree | Closeness | Radiality | Stress | Clustering coefficient |
|---|---|---|---|---|---|
| AKT1 | 10 | 14.916 67 | 4.571 43 | 242 | 0.111 11 |
| RELA | 9 | 14.666 67 | 4.619 05 | 150 | 0.277 78 |
| JUN | 9 | 14.833 33 | 4.666 67 | 210 | 0.250 00 |
| TNF | 8 | 14.000 00 | 4.523 81 | 206 | 0.321 43 |
| IKBKB | 5 | 12.333 33 | 4.333 33 | 62 | 0.400 00 |
| NOS2 | 5 | 12.666 67 | 4.428 57 | 42 | 0.600 00 |
| PPARG | 4 | 11.666 67 | 4.238 10 | 60 | 0.500 00 |
| CASP8 | 4 | 11.333 33 | 4.142 86 | 32 | 0.500 00 |
| MAPK8 | 4 | 11.250 00 | 4.095 24 | 42 | 0.333 33 |
| STAT1 | 3 | 11.000 00 | 4.142 86 | 24 | 0.666 67 |
| CASP3 | 3 | 10.500 00 | 3.952 38 | 18 | 0.333 33 |
| PIK3CA | 3 | 11.083 33 | 4.142 86 | 22 | 0.333 33 |
| PRKCA | 2 | 9.583 33 | 3.809 52 | 0 | 1.000 00 |
| VCAM1 | 2 | 9.250 00 | 3.666 67 | 76 | 0.000 00 |
| GSTP1 | 2 | 9.583 33 | 3.809 52 | 0 | 1.000 00 |
| BCL2 | 2 | 9.866 67 | 3.809 52 | 10 | 0.000 00 |
| CASP9 | 2 | 9.533 33 | 3.714 29 | 0 | 1.000 00 |
| INSR | 2 | 9.533 33 | 3.714 29 | 0 | 1.000 00 |
| NOS3 | 2 | 10.583 33 | 4.095 24 | 0 | 1.000 00 |
| SLC2A4 | 1 | 7.750 00 | 3.285 71 | 0 | 0 |
| ICAM1 | 1 | 6.683 33 | 2.714 29 | 0 | 0 |
| HMOX1 | 1 | 8.916 67 | 3.714 29 | 0 | 0 |
Tab. 3
Binding energy and binding sites between molecular docking of main active ingredients of monk fruit and key targets"
| Protein | Ligand | Affinity(kJ·mol-1) | Binding site |
|---|---|---|---|
| AKT1 | Kaempferol | -6.54 | LEU-52,GLU-40, GLN-47,LYS-59 |
RELA | Kaempferol | -7.18 | ASP-21,GLU-17, GLU-20,VAL-51, ASN-50,GLY-54 |
| JUN | Kaempferol | -5.07 | DT-215,DG-308, DC-310 |
TNF | Kaempferol | -7.32 | ASN-34,LEU-93, ARG-32,HIS-15, VAL-150 |
| IKBKB | Beta-sitosterol | -6.03 | GLN-743,LEU-742, TRP-741 |
| 1 | 莫梓沂, 刘 畅, 薛世圆, 等. 糖尿病肾病发病机制及治疗的研究进展[J]. 局解手术学杂志, 2021, 30(12): 1093-1098. |
| 2 | 陈雪芹, 汪裕伟. 糖尿病肾病治疗进展[J]. 湘南学院学报(医学版), 2022, 24(2): 73-78. |
| 3 | CHO N H, SHAW J E, KARURANGA S, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract, 2018, 138: 271-281. |
| 4 | UMANATH K, LEWIS J B. Update on diabetic nephropathy: core curriculum 2018[J]. Am J Kidney Dis, 2018, 71(6): 884-895. |
| 5 | 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)(上)[J]. 中国实用内科杂志, 2021,41(8): 668-695. |
| 6 | 徐天华, 姚 丽. 糖尿病肾病诊断及治疗新进展[J]. 中国实用内科杂志, 2022, 42(12): 1002-1006. |
| 7 | WANG L, WANG Z Y, YANG Z H, et al. Study of the active components and molecular mechanism of Tripterygium wilfordii in the treatment of diabetic nephropathy[J]. Front Mol Biosci, 2021, 8: 664416. |
| 8 | 欧珏平. 罗汉果甜苷提取物对人体代谢的影响研究[J]. 现代食品, 2023, 29(9): 219-221. |
| 9 | 余 华. 系统药理学关键预测技术开发及在中医药研究中的应用[D]. 杨凌: 西北农林科技大学, 2013. |
| 10 | 谈建成, 曾思恩. 罗汉果药用功能研究与进展[J]. 中国继续医学教育, 2019, 11(13): 147-149. |
| 11 | 袁 甜, 崔琳琳, 王 莹, 等. 中药网络药理学最新进展[J]. 中医药学报, 2021, 49(1): 101-106. |
| 12 | LI J S, ZHAO Z Z, MIAO X D, et al. Mechanism of Olibanum-Myrrha in treatment of rheumatoid arthritis based on network pharmacology and molecular docking[J]. China J Chin Mater Med, 2021, 46(10): 2371-2379. |
| 13 | WANG H H, CHEN W L, CUI Y Y, et al. Anhydroicaritin suppresses tumor progression via the PI3K/AKT signaling pathway in hepatocellular carcinoma[J]. Aging, 2023, 15(15): 7831-7843. |
| 14 | PAN J J, YANG H K, ZHU L H, et al. Qingfei Jiedu Decoction inhibits PD-L1 expression in lung adenocarcinoma based on network pharmacology analysis, molecular docking and experimental verification[J]. Front Pharmacol, 2022, 13: 897966. |
| 15 | GUO M F, DAI Y J, GAO J R, et al. Uncovering the mechanism of astragalus membranaceus in the treatment of diabetic nephropathy based on network pharmacology[J]. J Diabetes Res, 2020, 2020: 5947304. |
| 16 | QIANG P P, HAO J, YANG F, et al. Esaxerenone inhibits the macrophage-to-myofibroblast transition through mineralocorticoid receptor/TGF-β1 pathway in mice induced with aldosterone[J]. Front Immunol, 2022, 13: 948658. |
| 17 | 徐天华, 姚 丽. 糖尿病肾病诊断及治疗新进展[J].中国实用内科杂志,2022,42(12):1002-1006. |
| 18 | JIANG X S, XIANG X Y, CHEN X M, et al. Inhibition of soluble epoxide hydrolase attenuates renal tubular mitochondrial dysfunction and ER stress by restoring autophagic flux in diabetic nephropathy[J]. Cell Death Dis, 2020, 11(5): 385. |
| 19 | 崔丹丹. 罗汉果多糖提取分离、结构解析及对糖尿病肾病小鼠保护作用研究[D]. 西安: 陕西科技大学, 2021. |
| 20 | 李 涛, 邓放明, 覃 思, 等. Nrf2-ARE介导的黄酮类化合物抗氧化应激的研究进展[J]. 食品与机械, 2016, 32(6): 201-207. |
| 21 | LUO Q, ZHOU L, ZHOU N T, et al. Cost-effectiveness of insulin degludec/insulin aspart versus biphasic insulin aspart in Chinese population with type 2 diabetes[J]. Front Public Health, 2022, 10: 1016937. |
| 22 | 孙晓润, 陈苹苹, 林 悦, 等. 天然黄酮类化合物抗肿瘤作用靶点研究进展[J]. 中国实验方剂学杂志, 2017, 23(6): 218-228. |
| 23 | 吕 杰. 基于肾络癥瘕理论探讨炎症与糖尿病肾病的相关性[D]. 北京: 北京中医药大学, 2014. |
| 24 | LI Y, HAO H, YU H Z, et al. Ginsenoside Rg2 ameliorates myocardial ischemia/reperfusion injury by regulating TAK1 to inhibit necroptosis[J]. Front Cardiovasc Med, 2022, 9: 824657. |
| 25 | NAKAMURA T, FUKUI M, EBIHARA I, et al. mRNA expression of growth factors in glomeruli from diabetic rats[J]. Diabetes, 1993, 42(3): 450-456. |
| 26 | BAUD L, PEREZ J, FRIEDLANDER G, et al. Tumor necrosis factor stimulates prostaglandin production and cyclic AMP levels in rat cultured mesangial cells[J]. FEBS Lett, 1988, 239(1): 50-54. |
| 27 | LASTER S M, WOOD J G, GOODING L R. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis[J]. J Immunol, 1988, 141(8): 2629-2634. |
| 28 | NAVARRO J F, MILENA F J, MORA C, et al. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition[J]. Kidney Int Suppl, 2005(99): S98-S102. |
| 29 | 韩雨红, 董逸舒, 李雪蒙, 等. CXCL1通过促进蛋白激酶B磷酸化导致bEND.3小鼠脑微血管内皮细胞骨架收缩和通透性增加[J].细胞与分子免疫学杂志, 2023, 39(2): 117-123. |
| [1] | Shuang HAN,Jingwen HUANG,Yue SHI,Xinyue HUANG,Mengru GUO,Yi ZHENG,Ning MA. Network pharmacology analysis of mechanism of Taohong Siwu Decoction in treating periodontitis and its in vitro experimental validation [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 703-718. |
| [2] | Meng CAI,Yang GUO,Yingfang MA,Jinglei CUI,Jia LUO,Lili WEI,Yunhua ZHANG,Yang WANG. Therapeutic effect of prunetin on myocardial infarction model mice and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 125-134. |
| [3] | Huaimin LIANG,Jiacheng JIN,Wenhua CHEN,Yuyao LI,Hangyu WANG,Ke ZHANG,Jinhui WANG. UPLC-Q-TOF/MS and network pharmacology analysis and experimental verification based on potential active ingredients and mechanisms of medicinal Mulberry Leaves in anti-acute kidney injury [J]. Journal of Jilin University(Medicine Edition), 2026, 52(1): 56-69. |
| [4] | Bing BAI,Qian ZHANG,Tao PU,Yu NI,Tingting HU,Linhong HU,Yibin YANG. Effect of angiopoietin 1 and tyrosine kinase receptor 2 inhibitor on glucose transportation in endothelial cells and its mechanism [J]. Journal of Jilin University(Medicine Edition), 2025, 51(6): 1487-1497. |
| [5] | Xun LU,Chengxin MA,Jianan YANG,Xinxin GUO,Xiaobei XIE,Binghai ZHAO,Hongzhi LI. Research progress in mechanism of podocyte injury and its potential therapeutic strategies for diabetic nephropathy [J]. Journal of Jilin University(Medicine Edition), 2025, 51(5): 1415-1422. |
| [6] | Qiuyue WANG,Zhengning YANG,Xiaofeng HUANG,Minghan HUANG,Wenrong WANG. Network pharmacology and molecular docking analysis based on mechanism of Compound Gastritis Mixture in treatment of chronic atrophic gastritis [J]. Journal of Jilin University(Medicine Edition), 2025, 51(3): 691-702. |
| [7] | Xinchen ZHOU,Shuhan DONG,Zhuo ZHANG,Mingmei SHEN,Xiangjun WANG,Ying LI,Limei LIU. Network pharmacology analysis based on potential mechanism of dandelion-mulberry leaf in treatment of acute myeloid leukemia [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 1087-1097. |
| [8] | Shan CAO,Yijia ZHANG,Yang BAI,Fang CHEN,Sha XIE,Qianqian HAN. Network pharmacological analysis and in vitro experimental verification based on anti-atherosclerosis mechanism of Xiaoban Tongmai Formula [J]. Journal of Jilin University(Medicine Edition), 2024, 50(4): 925-938. |
| [9] | Zijia ZHU,Xia CHEN,Man CUI,Jihong WEN,Ping WANG,Dong SONG. Bioinformatics and molecular docking technology analysis on mechanism of salidroside on key differential genes of triple negative breast cancer [J]. Journal of Jilin University(Medicine Edition), 2024, 50(3): 759-769. |
| [10] | Haiyao PANG,Jun MENG. Research progress in relationship between 14-3-3ɛ protein and occurrence and development of tumor [J]. Journal of Jilin University(Medicine Edition), 2024, 50(2): 572-578. |
| [11] | Aiying CHEN,Jinwen JIANG,Hui ZHANG. Network pharmacology and molecular docking analysis based on mechanism of Huangqin Tang in treatment of colorectal cancer [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 208-220. |
| [12] | Li LIU,Linsheng HUANG,Yongheng ZHAO,Wenjie CAO,Yongshuai QIAN,Huifan YU,Fei LI. Network pharmacological analysis on Balanophora involucrataHook.f. in treatment of hyperuricemia and its therapeutic effect on hyperuricemia cell model and hyperuricemia model mouse [J]. Journal of Jilin University(Medicine Edition), 2024, 50(1): 58-70. |
| [13] | Jiaxin WANG,Zhenqi WANG,Xuan ZHANG. Expressions of CDKAL1 gene and its splice isomers in peripheral blood lymphocytes of patients with type 2 diabetes mellitus and their clinical significances [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1290-1295. |
| [14] | Chunling WANG,Sinuo WU,Xiaoyan YU,Weidong ZHANG. Analysis on network pharmacology and molecular docking technique based on effective chemical components and action targets of epimedium in treatment of hypothalamus-pituitary- adrenal gland/ gonad / thyroid gland axis function damage [J]. Journal of Jilin University(Medicine Edition), 2023, 49(5): 1296-1303. |
| [15] | Sihan LAI,Juntong LIU,Luying TAN,Jinping LIU,Pingya LI. Network pharmacology and molecular docking analysis on anti-ischemic stroke mechanism of Panax quinquefolium triolsaponins [J]. Journal of Jilin University(Medicine Edition), 2023, 49(4): 913-922. |